ライフサイエンスコーパス: palmitoleic acid

1 cells, enhancing the intracellular levels of palmitoleic acid.

2 oleic acid, but did contribute to growth on palmitoleic acid.

3 elaidic acid, trans-vaccenic acid and trans-palmitoleic acid.

4 leic acid, while less than 10% were based on palmitoleic acid.

5 l species, the lauric acid was replaced with palmitoleic acid.

6 their percentage concentrations of oleic and palmitoleic acids.

7 The monoenoic fatty acids palmitoleic acid (16:1 n-7) and oleic acid (18:1 n-9) we

8 levels of cholesterol ester and phospholipid palmitoleic acid (16:1) and oleic acid (18:1) and the le

9 ester myristic acid (14:0), and phospholipid palmitoleic acid (16:1), adrenic acid (22:4), and omega-

10 e revealed that recombinant SbDES2 converted palmitoleic acid (16:1Delta(9)) to hexadecadienoic acid

11 unguis-cati L.) vine accumulates nearly 80% palmitoleic acid (16:1Delta9) plus cis-vaccenic acid (18

12 d (20:4n-6) (B = 0.08, 95% CI: 0.002, 0.16), palmitoleic acid (16:1n-7) (B = 0.37, 95% CI: 0.04, 0.70

13 fatty acid biomarkers [myristic acid (14:0), palmitoleic acid (16:1n-7), 7-hexadecenoic acid (16:1n-9

14 ids in the DNL pathway-palmitic acid (16:0), palmitoleic acid (16:1n-7), 7-hexadecenoic acid (16:1n-9

15 Palmitic acid (16:0), stearic acid (18:0), palmitoleic acid (16:1n-7), and oleic acid (18:1n-9) are

16 t, after adjustment for confounding factors, palmitoleic acid (16:1n-7; P = 2.8 x 10(-7)), dihomo-gam

17 er the serum cholesteryl ester proportion of palmitoleic acid [16:1n-7 (16:1omega-3)] and the ratio o

18 In secondary analyses, palmitoleic acid, 16:1n-7 (HR, 1.11; 95% CI, 1.02-1.21;

19 or lowest compared with highest quintiles of palmitoleic acid: 2.27; 95% CI: 1.52, 3.38; P for trend

20 sociation of individual fatty acids were for palmitoleic acid (25.3 wk; 95% CI: 11.4, 39.2; P = 0.000

21 on inhibitors carbenoxolone (100 microM) and palmitoleic acid (50 microM) did not affect vasorelaxati

22 n decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti-inflammatory an

23 ce that the UbiK-UbiJ complex interacts with palmitoleic acid, a major lipid in E. coli Last, in Salm

24 Oleic acid, linoleic acid, and palmitoleic acid also stimulated activity; however, satu

25 posttranslational modification of Wnts with palmitoleic acid, an unsaturated lipid.

26 We report similarity between plasma palmitoleic acid and Crohn's disease and find that speci

27 association between plasma phospholipid cis- palmitoleic acid and heart failure risk in male physicia

28 warrants further research on adipose-derived palmitoleic acid and obesity risk.

29 Palmitoleic acid and oleic acid, two common C16 and C18

30 ression of genes that direct biosynthesis of palmitoleic acid and omega3 fatty acids.

31 Palmitoleic acid and SCD-1 were weakly inversely correla

32 amined whether the effects of adipose tissue palmitoleic acid and SCD1 activity were associated with

33 linoleic acid, myristic acid, palmitic acid, palmitoleic acid and the deoxycholate/cholate (DCA/CA) r

34 esence of inhibitory concentrations of bile, palmitoleic acid, and the small molecule inhibitor virst

35 lerae, which is otherwise disrupted by bile, palmitoleic acid, and virstatin.

36 uct was observed with both palmitic acid and palmitoleic acid as substrates.

37 re is no direct evidence that adipose tissue palmitoleic acid behaves as a lipokine to reduce obesity

38 rom E. coli (mixed-spin) = 228 +/- 2 mV; for palmitoleic acid-bound BioI = -199 +/- 2 mV).

39 (C18:0), and unsaturated fatty acids such as palmitoleic acid (C16:1), oleic acid (C18:1), and arachi

40 FA serum profiling revealed palmitoleic acid (C16:1n7) as a new molecular co-mediato

41 Sea buckthorn berries contain lipids rich in palmitoleic acid, carotenoids, tocols and sterols, but t

42 Animal experiments suggest that circulating palmitoleic acid (cis-16:1n-7) from adipocyte de novo fa

43 Palmitoleic acid (cis-16:1n-7), which is produced by end

44 positive association between adipose tissue palmitoleic acid concentrations and obesity (PR for lowe

45 The association between adipose tissue palmitoleic acid concentrations and obesity was attenuat

46 Studies in humans have evaluated only plasma palmitoleic acid concentrations, which reflect stearoyl-

47 accompanied by increases in plasma oleic and palmitoleic acid concentrations.

48 'DAT' cultivar was interesting for its high palmitoleic acid content while the 'GAL-E' and 'GAL-T' c

49 ately 75% suppression of the accumulation of palmitoleic acid, demonstrating that the physiologically

50 These apparent opposite effects of palmitoleic acid deserve further research in humans.

51 saturated TAGs containing oleic, linoleic or palmitoleic acids did not separate.

52 Palmitoleic acid ethyl ester (100 muM), an important med

53 Importantly, the palmitoleic acid ethyl ester-induced trypsin and proteas

54 stimulation and by the toxins bile acids and palmitoleic acid ethyl ester.

55 addition, wild type cells supplemented with palmitoleic acid exhibited an induction in PA phosphatas

56 ogenous fatty acids in the order of toxicity palmitoleic acid > oleic acid > palmitic acid.

57 Although plasma palmitoleic acid has been positively associated with blo

58 Changes in palmitoleic acid, however, did not reach significance wi

59 This unique form of lipidation with palmitoleic acid is a vital step in the biogenesis and s

60 of Or47b neurons to a stimulatory pheromone, palmitoleic acid, is low in young males but high in olde

61 e, L-glutamine, linoleic acid, pyruvic acid, palmitoleic acid, L-serine, oleic acid, myo-inositol, do

62 One site is dominated by a palmitoleic acid lipid group projecting from serine 187

63 i.e. lauric acid methyl ester, 1-dodecanol, palmitoleic acid, margaric acid, stearic acid, linolenic

64 nimal models have shown that adipose-derived palmitoleic acid may serve as a lipokine that contribute

65 with specific microbial metabolic pathways: palmitoleic acid metabolism and tryptophan degradation t

66 n FZD, blocking the interaction with the Wnt palmitoleic acid moiety.

67 4-hydroxyphenylpyruvic acid, palmitic acid, palmitoleic acid, myristoleic acid and total saturated f

68 Other fatty acids including linolenic acid, palmitoleic acid, myristoleic acid, stearic acid, palmit

69 Palmitic:palmitoleic acid (n-7 saturation index) was inversely as

70 The levels of palmitoleic acid, oleic acid, and palmitoleic acid to pa

71 ecific biomarkers, such as arachidonic acid, palmitoleic acid, oleic acid, propionylcarnitine, biliru

72 inistration of its C16:1 and C18:1 products, palmitoleic acid or oleate, protected cells from death.

73 Palmitoleic acid (P = 0.010) and the ratio of 16:1n-7 to

74 11-2.25) across consecutive quartiles of cis-palmitoleic acid (P for trend 0.009).

75 ophosphatidylcholine (LPC), oleic acid (OA), palmitoleic acid (PA), arachidonic acid (AA), and mixed

76 ry lipid metabolites, namely, oleic (OA) and palmitoleic acids (PA), to mitigate NF-kappaB-mediated i

77 The non-oxidative ethanol metabolites palmitoleic acid (POA) and POA-ethylester (POAEE) are re

78 polysis in CAAs, resulting in the release of palmitoleic acid (POA) into the TAME.

79 Palmitoleic acid (POA) is an n-7 monounsaturated fatty a

80 eas was produced by injection of ethanol and palmitoleic acid (POA), a nonoxidative metabolite of eth

81 Palmitoleic acid (POA), an FA with anti-inflammatory and

82 Caerulein and palmitoleic acid (POA)/ethanol-induced pancreatitis was

83 eam effector of 2AI-mediated AhR activation, palmitoleic acid protects RPE cells from 4HNE-mediated s

84 re identified, the predominant ones were cis-palmitoleic acid (pulp) and oleic and palmitic acid (pee

85 The finding that cis-palmitoleic acid reduces TCP and CT expression in V. cho

86 Key fatty acids, such as palmitic acid, palmitoleic acid, stearic acid, and oleic acid, were pro

87 products of Ole1p catalysis, oleic acid and palmitoleic acid, suppress mga2Delta spt23-ts and mga2De

88 trans Palmitoleic acid (t-16:1n-7, or 16:1 t9 in the delta nom

89 f 15:0, heptadecanoic acid [17:0], and trans-palmitoleic acid [t16:1n-7]) with CVD outcomes or all-ca

90 tabilized by interactions of one hydrophobic palmitoleic acid tail with two CRD palmitoleoyl-binding

91 conclude that SaOhyA protects S. aureus from palmitoleic acid, the antimicrobial unsaturated fatty ac

92 mutant were unaltered, although the ratio of palmitoleic acid to oleic acid was increased with a simi

93 levels of palmitoleic acid, oleic acid, and palmitoleic acid to palmitic acid (16:0) ratio were sign

94 omarkers pentadecanoic acid (15:0) and trans-palmitoleic acid (trans 16:1n-7) with type 2 diabetes tr

95 Plasma phospholipid concentrations of trans-palmitoleic acid (trans-16:1n-7), a biomarker of dairy f

96 15:0), heptadecanoic acid (C17:0), and trans-palmitoleic acid (trans-C16:1n-7) are correlates of dair

97 Each SD increase in plasma cis-palmitoleic acid was associated with 17% higher odds of

98 We assessed whether plasma phospholipid cis-palmitoleic acid was associated with heart failure risk.

99 , the sensitivity of the pah1Delta mutant to palmitoleic acid was not rescued by the dgk1Delta mutati

100 fatty acids, EPA, and the SI for palmitic to palmitoleic acid were associated with significantly lowe

101 mong tested cultivars, the highest shares of palmitoleic acid were determined in Golden Rain and Lucz

102 ne, tricosenoic acid, docosadienoic acid and palmitoleic acid were increased while serine, asparagine

103 tadecylic acid (C15:0, an odd-chain SFA) and palmitoleic acid were inversely correlated with joint de

104 d cis-11-eicoseneic acids and an increase in palmitoleic acid were observed.

105 Linoleic, linolenic, oleic, palmitic and palmitoleic acids were major in SBP oil, while VOP oil w

106 Unsaturated fatty acids (e.g., oleic and palmitoleic acids) were not subject to alpha oxidation,

107 of the Frizzled-4 (FZD4) CRD in complex with palmitoleic acid, which reveals a CRD tetramer consistin